Wiroj Mankhatitham

Suggest Changes
Learn More
To evaluate the rate of and risk factors for hepatotoxicity in tuberculosis (TB) and human immunodeficiency virus type 1 (HIV-1) co-infected patients while receiving non-nucleoside reverse(More)
  • 1